Moderna (LIM:MRNA) PB Ratio

: 3.00 (As of Today)

View and export this data going back to 2020. Start your Free Trial

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-23), Moderna's share price is $108.90. Moderna's Book Value per Share for the quarter that ended in Dec. 2023 was $36.27. Hence, Moderna's PB Ratio of today is 3.00.

The historical rank and industry rank for Moderna's PB Ratio or its related term are showing as below:

LIM:MRNA' s PB Ratio Range Over the Past 10 Years
Min: 1.98 Med: 4.3 Max: 28.61
Current: 2.88

During the past 8 years, Moderna's highest PB Ratio was 28.61. The lowest was 1.98. And the median was 4.30.

LIM:MRNA's PB Ratio is ranked worse than
57.56% of 1310 companies
in the Biotechnology industry
Industry Median: 2.36 vs LIM:MRNA: 2.88

During the past 12 months, Moderna's average Book Value Per Share Growth Rate was -27.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 78.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 76.70% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Moderna was 142.30% per year. The lowest was 78.10% per year. And the median was 96.10% per year.

Back to Basics: PB Ratio

Moderna PB Ratio Historical Data

The historical data trend for Moderna's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

17.91

6.78

4.23

2.70

Moderna Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
PB Ratio	Get a 7-Day Free Trial															4.23	2.82	3.11	2.84	2.70

Competitive Comparison

For the Biotechnology subindustry, Moderna's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moderna PB Ratio Distribution

For the Biotechnology industry and Healthcare sector, Moderna's PB Ratio distribution charts can be found below:

* The bar in red indicates where Moderna's PB Ratio falls into.

Moderna PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Moderna's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	108.90	/	36.267
	=	3.00

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Moderna (LIM:MRNA) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Moderna PB Ratio Related Terms

Thank you for viewing the detailed overview of Moderna's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Moderna (LIM:MRNA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (LIM:MRNA) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

MRNA:USA MRNA:Mexico 0QFd:UK 0A45:UK 0QF:Germany M1RN34:Brazil MRNA:Austria

Address

200 Technology Square, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.